February 20, 2018 Comments Off on Contribution of NIH funding to new drug approvals 2010–2016 Posted in: Guest content, Insights This article was originally published by Ekaterina Galkina Cleary, Jennifer M. Beierlein, Navleen Surjit Khanuja, Laura M. McNamee and Fred D. Ledley in PNAS under a Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC…
The po…
February 19, 2018 Comments Off on Understanding the Barriers to US Biosimilars Posted in: Insights Without a strong biosimilars market, costs for biologics in the US continue trending upward. The world of drug patents for biosimilars in the United States is far more complex than…
The post Understanding the Barriers to US Biosimilars appeared …